4DMT acquires all world-wide rights to short-form human complement factor H (sCFH) from Aevitas Therapeutics, Inc.; technology invented at University of Pennsylvania Announces sCFH as payload for ...

The complement signaling pathway plays an important role in injuries of the central nervous system (CNS), as well as in the progression of multiple sclerosis (MS). Investigators from Abzyme ...